{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:12:28Z","timestamp":1790089948797,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jep.2022.115599","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T02:04:51Z","timestamp":1659578691000},"page":"115599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial"],"prefix":"10.1016","volume":"298","author":[{"given":"Zhi-Min","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Quan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Gao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Li","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hai","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9111-9669","authenticated-orcid":false,"given":"Hui-Chun","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1696-6008","authenticated-orcid":false,"given":"Cheng-Hai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jep.2022.115599_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B","volume":"354","author":"Chang","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jep.2022.115599_bib2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jep.2022.115599_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2020.100601","article-title":"Safety and therapeutic effects of anti-fibrotic Traditional Chinese Medicine Fuzheng Huayu on persistent advanced stage fibrosis following 2 years entecavir treatment: study protocol for a single arm clinical objective performance criteria trial","volume":"19","author":"Chen","year":"2020","journal-title":"Contemp. Clin Trials Commun."},{"issue":"12","key":"10.1016\/j.jep.2022.115599_bib4","first-page":"895","article-title":"Common views on diagnosis and treatment of liver fibrosis in integrated traditional and western medicine (2017 update)","volume":"25","author":"Committee","year":"2017","journal-title":"Clin. J. Integr. Trad. West Med. Dig."},{"issue":"1","key":"10.1016\/j.jep.2022.115599_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.1501668","article-title":"Hepatocytes as immunological agents","volume":"196","author":"Crispe","year":"2016","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jep.2022.115599_bib6","first-page":"35","article-title":"Influence of \u201cHealth-supporting and stasis-resolving decoction\u201d on interstitial metalloproteinase activity in liver fibrosis rats","volume":"17","author":"Cui","year":"2003","journal-title":"J. Shanghai Univ. Tradl. Chin. Med."},{"issue":"7","key":"10.1016\/j.jep.2022.115599_bib7","first-page":"43","article-title":"The effects of Fuzheng Huayu recipe on collagen \u2163 expression and MMP-2 activity in rat fibrotic liver","volume":"14","author":"Cui","year":"2008","journal-title":"Chin. J. Exp. Tradl. Med. Formulae"},{"issue":"3","key":"10.1016\/j.jep.2022.115599_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.14218\/JCTH.2020.00004","article-title":"Histological outcome of Fuzheng Huayu plus entecavir combination therapy in chronic hepatitis B patients with significant liver fibrosis","volume":"8","author":"Gui","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"6","key":"10.1016\/j.jep.2022.115599_bib9","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jep.2022.115599_bib10","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(14)60921-5","article-title":"Sa1319 A phase II, randomized, placebo-controlled, double-blind, multi-center study to assess the antifibrotic activity of Fuzheng Huayu in chronic hepatitis C patients with hepatic fibrosis (S-USIIT-01)","volume":"146","author":"Hassanein","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jep.2022.115599_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jep.2022.115599_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00428-018-2340-2","article-title":"Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al","volume":"473","author":"Hytiroglou","year":"2018","journal-title":"Virchows Arch."},{"issue":"2","key":"10.1016\/j.jep.2022.115599_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group","volume":"339","author":"Lai","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.jep.2022.115599_bib14","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1365-2036.2007.03506.x","article-title":"Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B","volume":"26","author":"Lim","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jep.2022.115599_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1749-8546-4-12","article-title":"Effect of Fuzheng Huayu formula and its actions against liver fibrosis","volume":"4","author":"Liu","year":"2009","journal-title":"Chin. Med."},{"issue":"2","key":"10.1016\/j.jep.2022.115599_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3736\/jcim20030204","article-title":"[Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B]","volume":"1","author":"Liu","year":"2003","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"19","key":"10.1016\/j.jep.2022.115599_bib17","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3748\/wjg.v11.i19.2892","article-title":"Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B","volume":"11","author":"Liu","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.jep.2022.115599_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrgastro.2013.13","article-title":"Hepatitis: long-term therapy of chronic hepatitis B reverses cirrhosis","volume":"10","author":"Lok","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.jep.2022.115599_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/hep.29323","article-title":"Hepatitis B cure: from discovery to regulatory approval","volume":"66","author":"Lok","year":"2017","journal-title":"Hepatology"},{"issue":"9865","key":"10.1016\/j.jep.2022.115599_bib20","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jep.2022.115599_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cgh.2010.11.040","article-title":"Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B","volume":"9","author":"Schiff","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"11","key":"10.1016\/j.jep.2022.115599_bib22","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1111\/j.1572-0241.2008.02086.x","article-title":"Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis","volume":"103","author":"Schiff","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.jep.2022.115599_bib23","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1038\/s41598-018-21179-2","article-title":"Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak \"stable\" patients on anti-HBV therapy","volume":"8","author":"Sun","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jep.2022.115599_bib24","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/1472-6882-14-449","article-title":"Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-alpha induced hepatocyte apoptosis","volume":"14","author":"Tao","year":"2014","journal-title":"BMC Compl. Alternative Med."},{"issue":"8","key":"10.1016\/j.jep.2022.115599_bib25","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41379-018-0048-0","article-title":"Progression and regression of fibrosis in viral hepatitis in the treatment era: the Beijing classification","volume":"31","author":"Theise","year":"2018","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.jep.2022.115599_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3736\/jcim20120512","article-title":"[Chinese herbal medicine Fuzheng Huayu recipe inhibits liver fibrosis by mediating the transforming growth factor-beta1\/Smads signaling pathway]","volume":"10","author":"Wang","year":"2012","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.jep.2022.115599_bib27","article-title":"Clinical efficacy and safety of eight traditional Chinese medicine combined with entecavir in the treatment of chronic hepatitis B liver fibrosis in adults: a network meta-analysis","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid. Based Complement Alternat. Med."},{"issue":"11","key":"10.1016\/j.jep.2022.115599_bib28","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch. Pathol. Lab Med."},{"issue":"3","key":"10.1016\/j.jep.2022.115599_bib29","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10238-018-0501-x","article-title":"Longitudinal monitoring of liver fibrosis status by transient elastography in chronic hepatitis B patients during long-term entecavir treatment","volume":"18","author":"Wu","year":"2018","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.jep.2022.115599_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13880209.2019.1687527","article-title":"Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats","volume":"58","author":"Yang","year":"2020","journal-title":"Pharmaceut. Biol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122006389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874122006389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:25:55Z","timestamp":1759944355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874122006389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":30,"alternative-id":["S0378874122006389"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2022.115599","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of Fuzheng Huayu tablet on persistent advanced liver fibrosis following 2 years entecavir treatment: A single arm clinical objective performance criteria trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2022.115599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115599"}}